NIH-funded research NIH-funded research

Improving safety practices for research on dangerous pathogens

Official title: Core 2: BSL-3 Practices Core

Funded at Duke University · NIH-10910126 · Data updated 2026-11-12

This study is all about making sure that the lab where scientists work with serious germs, like the coronavirus and AIDS virus, is as safe as possible, so that the researchers can do their important work without risks, which could eventually help patients dealing with infectious diseases.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startAugust 18, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$895,157
NIH project number5UC7AI180254-02
Project IDNIH-10910126 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research include individuals affected by infectious diseases such as COVID-19 or AIDS.

Less likely to help

Patients with non-infectious conditions or those not affected by the targeted pathogens may not receive direct benefits from this research.

What this research studies

This research focuses on enhancing safety protocols and practices in a specialized laboratory that handles potentially dangerous pathogens, including the novel coronavirus and AIDS virus. The project aims to create a culture of continuous improvement in safety measures, ensuring that all staff are trained and equipped to conduct research safely. By refining standard operating procedures and providing additional safety personnel, the research seeks to maintain a secure environment for groundbreaking studies. Patients may benefit indirectly through improved research outcomes related to infectious diseases.

Why it matters

Potential benefit: If successful, this research could lead to safer and more effective treatments for infectious diseases, ultimately benefiting patients affected by these conditions.

How similar studies have gone: Other research in biocontainment and safety practices has shown success in improving research outcomes and safety, indicating that this approach is both tested and valuable.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Alderman, Scott — Duke University
  • Study coordinator: Alderman, Scott

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.